Css LLC Allakos Inc. Put Options Transaction History

Css LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 May 17, 2021	SELL	$109.73 - $153.66 $1.85 Million - $2.6 Million	-16,900 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$79.58 - $152.45 $485,438 - $929,944	6,100 Added 56.48%	16,900 $2.37 Million
Q3 2020 Nov 16, 2020	SELL	$66.43 - $90.99 $332,150 - $454,950	-5,000 Reduced 31.65%	10,800 $880,000
Q2 2020 Aug 14, 2020	BUY	$44.04 - $80.69 $246,624 - $451,864	5,600 Added 54.9%	15,800 $1.14 Million
Q1 2020 May 15, 2020	SELL	$44.49 - $93.39 $284,736 - $597,696	-6,400 Reduced 38.55%	10,200 $454,000
Q4 2019 Feb 14, 2020	BUY	$66.49 - $137.73 $1.1 Million - $2.29 Million	16,600 New	16,600 $1.58 Million

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $110M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.